Want to see AIRS full AI Analyst Report?
AIRS Stock Chart & Stats
$2.72
$0.15(3.25%)
At close: 4:00 PM EDT
$2.72
$0.15(3.25%)
Day’s Range― - ―
52-Week Range$1.15 - $11.93
Previous CloseN/A
Volume200.44K
Average Volume (3M)879.12K
Market Cap
$91.56M
Enterprise Value$371.18M
Total Cash (Recent Filing)$18.82M
Total Debt (Recent Filing)$70.47M
Price to Earnings (P/E)―
Beta2.50
Next Earnings
Nov 05, 2026EPS Estimate
-0.03Next Dividend Ex-DateN/A
Dividend Yield4.45%
Share Statistics
EPS (TTM)-0.18
Shares Outstanding72,095,210
10 Day Avg. Volume778,001
30 Day Avg. Volume879,118
Financial Highlights & Ratios
PEG Ratio-0.29
Price to Book (P/B)1.36
Price to Sales (P/S)0.79
P/FCF Ratio172.97
Enterprise Value/Market Cap4.05
Enterprise Value/Revenue2.46
Enterprise Value/Gross Profit4.27
Enterprise Value/Ebitda108.59
Forecast
1Y Price Target
$5.50Price Target Upside102.21% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)-0.08
Revenue Forecast (FY)$151.06M
Bulls Say, Bears Say
Bulls Say
Resilient Gross MarginGross margin around 61% shows that AirSculpt retains meaningful procedure-level economics despite weaker revenue. If sustained, this profitability cushion can support marketing, service expansion, and eventual operating leverage as volume stabilizes across the center network.
Improved Balance SheetSubstantial debt reduction, higher cash, and available revolver capacity improve financial flexibility over the next several quarters. A stronger capital base gives AirSculpt more ability to fund operations and strategic initiatives while reducing pressure from leverage and refinancing needs.
Service Portfolio ExpansionAdding procedures broadens the addressable patient base and increases the range of needs AirSculpt can serve within its existing centers. Wider offerings may improve clinician and facility utilization, diversify revenue sources, and create additional growth avenues beyond traditional fat-transfer procedures.
Bears Say
Sustained Revenue Decline And LossesThe multi-year revenue contraction indicates that AirSculpt has not yet restored demand to prior scale, while ongoing operating and net losses show gross profit is insufficient to cover the cost base. This weak earnings foundation limits internally funded growth and raises execution risk.
Recent Cash BurnThe shift from several years of positive operating and free cash flow to TTM cash burn weakens financial self-sufficiency. Continued negative cash generation could consume liquidity, constrain investment in centers and marketing, and make future balance-sheet improvement more dependent on external financing.
Customer Acquisition PressureHigher acquisition costs make each new case less economically attractive and require greater marketing efficiency to sustain growth. Combined with a projected Q3 comparable-revenue decline, this suggests demand conversion remains challenging and may delay operating leverage even as the company invests more in promotion.
Airsculpt Technologies News
AIRS FAQ
What was Airsculpt Technologies, Inc.’s price range in the past 12 months?
Airsculpt Technologies, Inc. lowest stock price was $1.15 and its highest was $11.93 in the past 12 months.
What is Airsculpt Technologies, Inc.’s market cap?
Airsculpt Technologies, Inc.’s market cap is $91.56M.
When is Airsculpt Technologies, Inc.’s upcoming earnings report date?
Airsculpt Technologies, Inc.’s upcoming earnings report date is Nov 05, 2026 which is in 8 days.
How were Airsculpt Technologies, Inc.’s earnings last quarter?
Airsculpt Technologies, Inc. released its earnings results on Aug 10, 2026. The company reported $0.01 earnings per share for the quarter, missing the consensus estimate of $0.015 by -$0.005.
Is Airsculpt Technologies, Inc. overvalued?
According to Wall Street analysts Airsculpt Technologies, Inc.’s price is currently Undervalued.
Does Airsculpt Technologies, Inc. pay dividends?
Airsculpt Technologies, Inc. pays a Notavailable dividend of $0.41 which represents an annual dividend yield of 4.45%. See more information on Airsculpt Technologies, Inc. dividends here
What is Airsculpt Technologies, Inc.’s EPS estimate?
Airsculpt Technologies, Inc.’s EPS estimate is -0.03.
How many shares outstanding does Airsculpt Technologies, Inc. have?
Airsculpt Technologies, Inc. has 72,095,210 shares outstanding.
What happened to Airsculpt Technologies, Inc.’s price movement after its last earnings report?
Airsculpt Technologies, Inc. reported an EPS of $0.01 in its last earnings report, missing expectations of $0.015. Following the earnings report the stock price went down -45.11%.
Which hedge fund is a major shareholder of Airsculpt Technologies, Inc.?
Currently, no hedge funds are holding shares in AIRS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Airsculpt Technologies Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$5.50 (102.21% Upside)
$5.50 (102.21% Upside)
Blogger Sentiment
Bullish
AIRS Sentiment 67%
Sector Average 66%
Sector Average 66%
Hedge Fund Trend
Increased
By 171.2K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Negative
20 days / 200 days
Momentum
-89.72%
12-Months-Change
Fundamentals
Return on Equity
-12.52%
Trailing 12-Months
Asset Growth
-2.56%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Airsculpt Technologies, Inc.
AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States, Canada, and the United Kingdom. The company offers AirSculpt, a body contouring treatment that removes fat and tightens skin while sculpting targeted areas of the body in a minimally invasive procedure. It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an advanced cellulite removal tool. In addition, it provides fat removal procedures across treatment areas, such as the stomach, back, and buttocks; and fat transfer procedures that transfers the patient’s own fat cells to enhance the buttocks, breasts, hips, aging hands, or other areas. Further, the company’s body contouring procedures include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. Additionally, it operates various centers. AirSculpt Technologies, Inc. was founded in 2012 and is headquartered in Miami Beach, Florida.
AIRS Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a balanced picture: the company demonstrated measurable stabilization (case growth, improved same-center sales, gross margin expansion, reduced debt and increased liquidity) and a clear strategic plan (new procedures, AlloClae partnership, marketing optimization). However, near-term headwinds persist — Q2 revenue modestly declined, adjusted EBITDA was down versus prior year, customer acquisition costs are elevated, and trends softened in June/July with Q3 expected to be down on a comparable basis. Management is investing in marketing and new services to drive longer-term growth but those investments and new offerings are early-stage and have not yet been fully realized in the financials.View all AIRS earnings summariesAIRS Stock 12 Month Forecast
Average Price Target
$5.50
▲(102.21% Upside)
Technical Analysis
AMN Healthcare Services
―
Community Health
―
―
Healthcare Services
―
National Healthcare
―
Ownership Overview
47.16% Insiders
1.25% Mutual Funds
0.41% Other Institutional Investors
49.53% Public Companies and
Individual Investors